milrinone has been researched along with Pregnancy in 15 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone has been proposed as an effective treatment for pulmonary hypertension (PH) and right ventricular (RV) dysfunction." | 7.81 | Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series. ( Bee, C; Corcoran, JD; El-Khuffash, AF; Franklin, O; James, AT; McNamara, PJ, 2015) |
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 5.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| "Pretreatment with milrinone markedly enhanced relaxation to prostacyclin and iloprost in PPHN PA, similar to relaxation in control PA." | 5.35 | Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. ( Chen, B; Farrow, KN; Gugino, SF; Kumar, VH; Lakshminrusimha, S; Porta, NF; Russell, JA; Steinhorn, RH, 2009) |
| "Milrinone has been proposed as an effective treatment for pulmonary hypertension (PH) and right ventricular (RV) dysfunction." | 3.81 | Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series. ( Bee, C; Corcoran, JD; El-Khuffash, AF; Franklin, O; James, AT; McNamara, PJ, 2015) |
| " The differential effects of these PDE 3 inhibitors on the near-term and preterm ductus were studied by injecting indomethacin (10 mg/kg) and PDE 3 inhibitors into 21D (21st day of pregnancy: term-21." | 3.73 | In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. ( Imamura, S; Momma, K; Nakanishi, T; Toyoshima, K, 2006) |
| " These drugs must be administered parenterally and have a half-life of only a few minutes." | 2.40 | Clinical pharmacokinetics of vasodilators. Part II. ( Heintz, B; Kirsten, D; Kirsten, R; Nelson, K, 1998) |
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 1.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| "Pretreatment with milrinone markedly enhanced relaxation to prostacyclin and iloprost in PPHN PA, similar to relaxation in control PA." | 1.35 | Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. ( Chen, B; Farrow, KN; Gugino, SF; Kumar, VH; Lakshminrusimha, S; Porta, NF; Russell, JA; Steinhorn, RH, 2009) |
| "Milrinone is an inotropic agent for short-term intravenous use in the management of congestive heart failure." | 1.29 | Placental transfer of milrinone in the nonhuman primate (baboon). ( Atkinson, BD; Fishburne, JI; Hales, KA; Levy, GH; Rayburn, WF, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hadhiah, KM | 1 |
| Alshagawi, ZA | 1 |
| Alzahrani, SK | 1 |
| Alrayes, MM | 1 |
| Aldandan, HW | 1 |
| Baxter, FJ | 1 |
| Whippey, A | 1 |
| Dasgupta, S | 1 |
| Qasim, A | 1 |
| Aly, AM | 1 |
| Jain, SK | 1 |
| Perumal, G | 1 |
| Marathe, SP | 1 |
| Schlapbach, LJ | 1 |
| Morwood, J | 1 |
| Venugopal, P | 1 |
| Alphonso, N | 1 |
| James, AT | 1 |
| Bee, C | 1 |
| Corcoran, JD | 1 |
| McNamara, PJ | 1 |
| Franklin, O | 1 |
| El-Khuffash, AF | 1 |
| Radulova, P | 1 |
| Vakrilova, L | 1 |
| Slancheva, B | 1 |
| Lakshminrusimha, S | 1 |
| Porta, NF | 1 |
| Farrow, KN | 1 |
| Chen, B | 1 |
| Gugino, SF | 1 |
| Kumar, VH | 1 |
| Russell, JA | 1 |
| Steinhorn, RH | 1 |
| Miura, Y | 1 |
| Matsuda, T | 1 |
| Funakubo, A | 1 |
| Watanabe, S | 1 |
| Kitanishi, R | 1 |
| Saito, M | 1 |
| Hanita, T | 1 |
| Bassler, D | 1 |
| Choong, K | 1 |
| McNamara, P | 1 |
| Kirpalani, H | 1 |
| Toyoshima, K | 1 |
| Momma, K | 1 |
| Imamura, S | 1 |
| Nakanishi, T | 1 |
| Atkinson, BD | 1 |
| Fishburne, JI | 1 |
| Hales, KA | 1 |
| Levy, GH | 1 |
| Rayburn, WF | 1 |
| Kirsten, R | 1 |
| Nelson, K | 1 |
| Kirsten, D | 1 |
| Heintz, B | 1 |
| Wiersma, A | 1 |
| Hirsch, B | 1 |
| Tsafriri, A | 1 |
| Hanssen, RG | 1 |
| Van de Kant, M | 1 |
| Kloosterboer, HJ | 1 |
| Conti, M | 1 |
| Hsueh, AJ | 1 |
| Jelsema, RD | 1 |
| Santos, AC | 1 |
| Baumann, AL | 1 |
| Wlody, D | 1 |
| Pedersen, H | 1 |
| Morishima, HO | 1 |
| Finster, M | 1 |
2 reviews available for milrinone and Pregnancy
| Article | Year |
|---|---|
[BRONCHOPULMONARY DYSPLASIA--WHAT DO WE KNOW TODAY?].
Topics: Antihypertensive Agents; Birth Weight; Bronchodilator Agents; Bronchopulmonary Dysplasia; Epoprosten | 2015 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilo | 1998 |
13 other studies available for milrinone and Pregnancy
| Article | Year |
|---|---|
Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
Topics: Adult; Cerebrovascular Disorders; Eclampsia; Female; Headache Disorders, Primary; Humans; Milrinone; | 2021 |
Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report.
Topics: Cesarean Section; Embolism, Amniotic Fluid; Female; Humans; Milrinone; Pregnancy; Shock; Vascular Re | 2020 |
Mother With Diabetes Mellitus and Infant With Hypertrophic Obstructive Cardiomyopathy: Milrinone Precluded Need for Extracorporeal Membrane Oxygenation.
Topics: Biomarkers; Blood Glucose; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Diabetes, Gestational; | 2017 |
Postoperative catecholamine resistance following fetal methamphetamine exposure.
Topics: Amphetamine-Related Disorders; Cardiotonic Agents; Central Nervous System Stimulants; Dopamine; Drug | 2019 |
Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series.
Topics: Blood Pressure; Echocardiography; Female; Fetofetal Transfusion; Humans; Hypertension, Pulmonary; In | 2015 |
Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn.
Topics: Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Drug Interactions; Drug Therap | 2009 |
Novel modification of an artificial placenta: pumpless arteriovenous extracorporeal life support in a premature lamb model.
Topics: Animals; Arterial Pressure; Artificial Organs; Disease Models, Animal; Dopamine; Equipment Design; E | 2012 |
Neonatal persistent pulmonary hypertension treated with milrinone: four case reports.
Topics: Administration, Inhalation; Animals; Female; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infa | 2006 |
In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Animals, Newborn; Cyclic Nucleotide Phosphodiesterases | 2006 |
Placental transfer of milrinone in the nonhuman primate (baboon).
Topics: Animals; Cardiotonic Agents; Female; Fetal Blood; Infusions, Intravenous; Milrinone; Papio; Placenta | 1996 |
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Contraceptive Agents, Fem | 1998 |
Milrinone use in the pregnant ewe.
Topics: Animals; Cardiotonic Agents; Female; Fetus; Milrinone; Pregnancy; Pregnancy, Animal; Pyridones; Shee | 1992 |
The maternal and fetal effects of milrinone and dopamine in normotensive pregnant ewes.
Topics: Acid-Base Equilibrium; Amnion; Animals; Blood Pressure; Central Venous Pressure; Dopamine; Female; F | 1992 |